SEC Form 4 · accession 0001325812-15-000045
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin P Starr
Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $131.21 | Jun 1, 2015 | A | 11,250 | A | Jun 1, 2016 | Jun 1, 2025 | Common Stock | 11,250 | 11,250 | D |